Latest SEEL reports update at 2024-05-14: 2024-Q12023-Q42023-Q1
Seelos Therapeutics logo
Seelos Therapeutics SEEL
$ 1.2 -1.64%

Seelos Therapeutics EV/EBITDA Ratio 2011-2024 | SEEL

Annual EV/EBITDA Ratio Seelos Therapeutics

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-0.622 -5.11 -0.391 0.025 -2.13 -1.52 -2.9 -2 -3.21 -7.1 -5.48

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
0.025 -7.1 -2.77